default author photo

Zhong-Ping Yang

Chongqing Public Health Medical Center - National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine

Chongqing, 400036

China

SCHOLARLY PAPERS

1

DOWNLOADS

191

TOTAL CITATIONS

3

Scholarly Papers (1)

1.

Comparative Effectiveness and Safety of Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients with Mild to Moderate Novel Coronavirus Pneumonia: Results of a Randomized, Open-Labeled Prospective Study

Number of pages: 38 Posted: 05 May 2020
Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases, Chongqing Public Health Medical Center - Department of Infectious Diseases and Chongqing Public Health Medical Center - National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine
Downloads 191 (397,477)
Citation 3

Abstract:

Loading...

Ribavirin; Interferon-alpha; Lopinavir/ritonavir; Mild to Moderate COVID-19; Effectiveness and Safety